Upcoming Webinar

Natera at SMFM:

EXPAND trial data and the future of single-gene NIPT

Date: Tuesday, March 17, 2026

Time: 10:00 AM PT | 1:00 PM ET

Webinar duration: 45-minutes

Registrants will receive a recording of the webinar approximately one week after the event.

Join us for a deep dive into Natera’s latest data freshly presented at SMFM 2026. This webinar will provide a comprehensive analysis of the data from the EXPAND study presented during the first oral plenary session at SMFM. Explore the evolution of NIPT and the expanding clinical insights available through single-gene NIPT, the latest innovation in cfDNA screening.

EXPAND is a prospective clinical trial to develop and validate Fetal Focus™ single-gene NIPT for inherited conditions. Powered by Natera’s proprietary, ultra-sensitive LinkedSNP™ technology, Fetal Focus™ assesses whether a fetus has inherited disease-causing variants from one or both parents, analyzing 21 genes associated with serious, early-onset medical conditions.

“Being selected for an oral plenary presentation at SMFM is a wonderful achievement and reflects the thoughtful approach Natera’s clinical trials team has taken to validate Fetal Focus™. NIPT for inherited single-gene conditions is an emerging test category and the team at Natera is excited to share the data supporting our new test offering.”

-Jeffrey Dungan, MD, FACOG, FACMG, Medical Director Women's Health, Natera

Don't miss this opportunity to see how this landmark study is redefining the standard of care in prenatal genetic testing.

Natera Honey Pot

Register Now:

First Name*

Last Name*

Email Address*

Job Title*

Phone*

Company Name*

Postal Code*

Country*

I am a*

Do you have any questions for the presenters that you would like to submit before the webinar?

Please fill in the field above only if you have specific questions. Otherwise, leave it blank.

Natera would like to send you information about our products and services. You may unsubscribe from these communications at any time.

Hear from our speakers

Michelle Owens, MD, MS, FACOG

Maternal Fetal-Medicine Specialist

Faculty, Ascension St. Vincent’s Hospital

Jeffrey Dungan, MD, FACOG, FACMG

Medical Director, Women's Health, Natera

The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the tests. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2026 Natera, Inc. All Rights Reserved.

13011 McCallen Pass, Building A Suite 100 | Austin, TX 78753 | natera.com | Do Not Share My Personal Information | Privacy Policy